|
1
|
Global Action Plan on the Public Health
Response to Dementia 2017-2025. World Health Organization, Geneva,
2017.
|
|
2
|
Orme RP, Middleditch C, Waite L and
Fricker RA: The Role of Vitamin D3 in the development
and neuroprotection of midbrain dopamine neurons. Vitam Horm.
100:273–297. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wrzosek M, Łukaszkiewicz J, Wrzosek M,
Jakubczyk A, Matsumoto H, Piątkiewicz P, Radziwoń-Zaleska M, Wojnar
M and Nowicka G: Vitamin D and the central nervous system.
Pharmacol Rep. 65:271–278. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Littlejohns TJ, Henley WE, Lang IA,
Annweiler C, Beauchet O, Chaves PH, Fried L, Kestenbaum BR, Kuller
LH, Langa KM, et al: Vitamin D and the risk of dementia and
Alzheimer disease. Neurology. 83:920–928. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Afzal S, Bojesen SE and Nordestgaard BG:
Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and
vascular dementia. Alzheimers Dement. 10:296–302. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gezen-Ak D, Yilmazer S and Dursun E: Why
Vitamin D in Alzheimer's Disease? The Hypothesis. J Alzheimers Dis.
40:257–269. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Landel V, Annweiler C, Millet P, Morello M
and Féron F: Vitamin D, Cognition and Alzheimer's Disease: The
Therapeutic benefit is in the D-Tails. J Alzheimers Dis.
53:419–444. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mavraki E, Ioannidis P, Tripsianis G,
Gioka T, Kolousi M and Vadikolias K: Vitamin D in mild cognitive
impairment and Alzheimer's disease. A study in older Greek adults.
Hippokratia. 24:120–126. 2020.PubMed/NCBI
|
|
9
|
Gezen-Ak D, Dursun E and Yilmazer S: The
effect of Vitamin D treament On Nerve Growth Factor (NGF) Release
from Hippocampal Neurons. Noro Psikiyatr Ars. 51:157–162.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Dursun E, Gezen-Ak D and Yilmazer S: The
Influence of Vitamin D treatment on the Inducible Nitric Oxide
Synthase (INOS) Expression in Primary Hippocampal Neurons. Noro
Psikiyatr Ars. 51:163–168. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gradinaru D, Borsa C, Ionescu C, Margina
D, Prada GI and Jansen E: Vitamin D status and oxidative stress
markers in the elderly with impaired fasting glucose and type 2
diabetes mellitus. Aging Clin Exp Res. 24:595–602. 2012.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Mizwicki MT, Menegaz D, Zhang J,
Barrientos-Durán A, Tse S, Cashman JR, Griffin PR and Fiala M:
Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3
Promotes the Recovery of Amyloid-β Phagocytosis by Alzheimer's
Disease Macrophages. J Alzheimers Dis. 29:51–62. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mizwicki MT, Liu G, Fiala M, Magpantay L,
Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ,
et al: 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance
between amyloid-β phagocytosis and inflammation in Alzheimer's
disease patients. J Alzheimers Dis. 34:155–170. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gezen-Ak D, Dursun E and Yilmazer S: The
effects of vitamin D receptor silencing on the expression of
LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons.
PLoS One. 6(e17553)2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cui X, Gooch H, Petty A, McGrath JJ and
Eyles D: Vitamin D and the brain: Genomic and non-genomic actions.
Mol Cell Endocrinol. 453:131–143. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gezen-Ak D, Dursun E, Ertan T, Hanagasi H,
Gurvit H, Emre M, Eker E, Ozturk M, Engin F and Yilmazer S:
Association between Vitamin D receptor gene polymorphism and
Alzheimer's disease. Tohoku J Exp Med. 212:275–282. 2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lehmann DJ, Refsum H, Warden DR, Medway C,
Wilcock GK and Smith AD: The vitamin D receptor gene is associated
with Alzheimer's disease. Neurosci Lett. 504:79–82. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Esfehani NT, Rahgozar M and Biglarian A:
Identification of genetic polymorphism interactions in sporadic
Alzheimer's disease using logic regression. Iran Rehabil J.
9:45–50. 2011.
|
|
19
|
Gezen-Ak D, Dursun E, Bilgic B, Hanagasi
H, Ertan T, Gurvit H, Emre M, Eker E, Ulutin T, Uysal O and
Yilmazer S: Vitamin D receptor gene haplotype is associated with
late onset Alzheimer's disease. Tohoku J Exp Med. 228:189–196.
2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Khorram Khorshid HR, Gozalpour E,
Saliminejad K, Karimloo M, Ohadi M and Kamali K: Vitamin D receptor
(VDR) polymorphisms and late-onset Alzheimer's disease: An
association study. Iran J Publ Health. 42:1253–1258.
2013.PubMed/NCBI
|
|
21
|
Łaczmański L, Jakubik M,
Bednarek-Tupikowska G, Rymaszewska J, Słoka N and Lwow F: Vitamin D
receptor gene polymorphisms in Alzheimer's disease patients. Exp
Gerontol. 69:142–147. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Oliveira ACR, Magalhães CA, Loures CMG,
Fraga VG, de Souza LC, Guimarães HC, Cintra MTG, Bicalho MA, Sousa
MCR, Silveira JN, et al: BsmI polymorphism in the vitamin D
receptor gene is associated with 25-hydroxy vitamin D levels in
individuals with cognitive decline. Arq Neuropsiquiatr. 76:760–766.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Poduslo SE and Yin X: Chromosome 12 and
late-onset Alzheimer's disease. Neurosci Lett. 310:188–190.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gezen-Ak D and Dursun E: Molecular basis
of vitamin D action in neurodegeneration: The story of a team
perspective. Hormones (Athens). 18:17–21. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gezen-Ak D, Atasoy IL, Candaş E,
Alaylioglu M, Yılmazer S and Dursun E: Vitamin D receptor regulates
amyloid beta 1-42 production with protein disulfide isomerase A3.
ACS Chem Neurosci. 8:2335–2346. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sutherland MK, Somerville MJ, Yoong LK,
Bergeron C, Haussler MR and McLachlan DR: Reduction of vitamin D
hormone receptor mRNA levels in Alzheimer as compared to huntington
hippocampus: Correlation with calbindin-28k mRNA levels. Brain Res
Mol Brain Res. 13:239–250. 1992.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Landel V, Millet P, Baranger K, Loriod B
and Féron F: Vitamin D interacts with Esr1 and Igf1 to regulate
molecular pathways relevant to Alzheimer's disease. Mol
Neurodegener. 11(22)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Gubandru M, Margina D, Tsitsimpikou C,
Goutzourelas N, Tsarouhas K, Ilie M, Tsatsakis AM and Kouretas D:
Alzheimer's disease treated patients showed different patterns for
oxidative stress and inflammation markers. Food Chem Toxicol.
61:209–214. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nitulescu GM, Van De Venter M, Nitulescu
G, Ungurianu A, Juzenas P, Peng Q, Olaru OT, Gradinaru D, Tsatsakis
A, Tsoukalas D, et al: The Akt pathway in oncology therapy and
beyond (Review). Int J Oncol. 53:2319–2331. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zaulkffali AS, Md Razip NN, Syed Alwi SS,
Abd Jalil A, Abd Mutalib MS, Gopalsamy B, Chang SK, Zainal Z,
Ibrahim NN, Zakaria ZA and Khaza'ai H: Vitamins D and E stimulate
the PI3K-AKT signalling pathway in insulin-resistant SK-N-SH
neuronal cells. Nutrients. 11(2525)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang D, Wang L, Zhang R and Li S:
Association of vitamin D receptor gene polymorphisms and the risk
of multiple sclerosis: A meta-analysis. Arch Med Res. 50:350–361.
2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Niu MY, Wang L and Xie AM: ApaI, BsmI,
FokI, and TaqI polymorphisms in the vitamin D receptor gene and
Parkinson's disease. Chin Med J (Engl). 128:1809–1814.
2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Papasavva M, Vikelis M, Siokas V, Katsarou
MS, Dermitzakis E, Raptis A, Dardiotis E and Drakoulis N: VDR gene
polymorphisms and cluster headache susceptibility: Case-control
study in a Southeastern European caucasian population. J Mol
Neurosci. 72:382–392. 2022.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Geng J, Zhang J, Yao F, Liu X, Liu J and
Huang Y: A systematic review and meta-analysis of the associations
of vitamin D receptor genetic variants with two types of most
common neurodegenerative disorders. Aging Clin Exp Res. 32:21–27.
2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mun MJ, Kim MS, Kim JH and Jang WC: A TaqI
polymorphism of vitamin D receptor is associated with Alzheimer's
disease in Korean population: A case-control study. Int J Clin Exp
Med. 9:19268–19279. 2016.
|
|
36
|
Kuningas M, Mooijaart SP, Jolles J,
Slagboom PE, Westendorp RG and Van Heemst D: VDR gene variants
associate with cognitive function and depressive symptoms in old
age. Neurobiol Aging. 30:466–473. 2009.PubMed/NCBI View Article : Google Scholar
|
